VerAvanti Inc.

Overview

VerAvanti Inc. is a medical technology company specializing in advanced intravascular imaging solutions. It has developed the Scanning Fiber Endoscope (SaFE) technology to improve diagnostic accuracy and patient safety in cardiology and neurosurgery. With a team of engineering graduates from the University of Washington, the company holds more than 50 U.S. patents and has secured over $33 million in funding.

The Scanning Fiber Endoscope (SFE) is an ultrathin, single-use device that deploys advanced scanning laser light technology for high-resolution, multimodal imaging. This enables improved visualization of intravascular structures and addresses the limitations of traditional imaging methods, focusing on minimally invasive procedures such as early cancer diagnosis and surgical guidance. FDA approval is expected by early 2026, with plans for a global market launch targeting healthcare providers in interventional cardiology, neurosurgery, and peripheral artery interventions.

Basic Information

Contact Details

• Phone: +1 425-201-6070
• Website: veravanti.com
• LinkedIn: linkedin.com/company/veravanti-inc

Key Focus Areas & Initiatives

• Scanning Fiber Endoscope (SaFE) technology
• Advanced intravascular imaging
• Minimally invasive applications
• High-resolution imaging
• Diagnostic accuracy
• Patient safety
• Single-use endoscopic devices
• FDA approval and clinical validation
• Neurovascular and cardiovascular imaging
• Early cancer diagnosis
• Surgical guidance solutions
• Healthcare innovation

Technologies Used

• Google Cloud Hosting
• Google Maps
• IoT
• Mobile Friendly
• Outlook
• Remote
• Typekit
• Varnish
• Wix
• WordPress.org

Affiliated Organizations & Regional Branches